Mitochondria are dynamic organelles that have been linked to stem cell homeostasis. However, the mechanisms involved in mitochondrial regulation of stem cell fate determination remain elusive. Here we discover that epithelial-mesenchymal transition (EMT), a key process in cancer progression, induces mitochondrial fusion through regulation of the miR200c-PGC1α-MFN1 pathway. EMT-activated MFN1 forms a complex with PKCζ and is required for PKCζ-mediated NUMB phosphorylation and dissociation from the cortical membrane to direct asymmetric division of mammary stem cells, where fused mitochondria are tethered by MFN1-PKCζ to the cortical membrane and asymmetrically segregated to the stem cell-like progeny with enhanced glutathione synthesis and reactive oxygen species scavenging capacities, allowing sustaining of a self-renewing stem cell pool. Suppression of MFN1 expression leads to equal distribution of the fragmented mitochondria in both progenies that undergo symmetric luminal cell differentiation. Together, this study elucidates an essential role of mitofusin in stem cell fate determination to mediate EMT-associated stemness.
Pubmed ID: 30527740 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD44
View all literature mentionsThis polyclonal targets CDH1
View all literature mentionsThis unknown targets Lineage Cocktail with Isotype Control
View all literature mentionsThis monoclonal targets TCF8/ZEB1 (D80D3) Rabbit mAb
View all literature mentionsThis monoclonal targets Vimentin
View all literature mentionsThis monoclonal targets PKC zeta antibody [EP1490(2)]
View all literature mentionsThis monoclonal targets MFN1
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis polyclonal targets Cytokeratin 8
View all literature mentionsThis monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH
View all literature mentionsThis monoclonal targets Phospho-Numb (Ser276) (D5C2) Rabbit mAb
View all literature mentionsThis unknown targets His-tag
View all literature mentionsThis monoclonal targets PGC-1α
View all literature mentionsThis monoclonal targets ND
View all literature mentionsThis monoclonal targets NEW Numb clone 6G10.1
View all literature mentionsThis monoclonal targets Cytokeratin 14
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis unknown targets DIG
View all literature mentionsThis monoclonal targets TCF8/ZEB1 (D80D3) Rabbit mAb
View all literature mentionsThis monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH
View all literature mentionsThis monoclonal targets ND
View all literature mentionsThis unknown targets His-tag
View all literature mentionsThis monoclonal targets PGC-1α
View all literature mentionsThis monoclonal targets MFN1
View all literature mentionsThis polyclonal targets CDH1
View all literature mentionsThis unknown targets DIG
View all literature mentionsThis monoclonal targets Cytokeratin 14
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal targets Cytokeratin 8
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets PKC zeta antibody [EP1490(2)]
View all literature mentionsThis unknown targets Lineage Cocktail with Isotype Control
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis monoclonal targets Phospho-Numb (Ser276) (D5C2) Rabbit mAb
View all literature mentionsThis monoclonal targets Vimentin
View all literature mentionsThis monoclonal targets NEW Numb clone 6G10.1
View all literature mentions